Satellos Bioscience Inc. Announces Pricing of Proposed Offering of Units

Toronto, Ontario--(Newsfile Corp. - August 30, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change

Related Keywords

United States ,United Kingdom ,Canada ,Toronto ,Ontario ,British ,Christina Cameron ,Ryan Mitchell ,Michael Rudnicki ,Company Units ,Leede Jones Gable Inc ,Amphotericinb Technologies Inc ,Bloom Burton Securities Inc ,Pi Financial Corp ,Companya Common Share ,Regulatory Services Provider ,Newsfile Corp ,Satellos Bioscience Inc ,Venture Exchange ,Business Development ,Common Share ,Each Warrant ,Computershare Trust Company ,Leede Jones Gable ,Each Compensation Option ,Compensation Options ,Restated Preliminary ,British Columbia ,Restated Preliminary Prospectus ,Common Shares ,United States Securities Act ,Warrant Indenture ,Annual Information Form ,Although Satellos ,Satellos ,Ioscience ,Nnounces ,Ricing ,Roposed ,Offering ,Units ,